Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPST-1495 in Familial Adenomatous Polyposis (FAP)
NCT06557733Phase 2Recruiting
- Sponsor
- National Cancer Institute
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tpst-1495 in familial adenomatous polyposis (FAP), sponsored by National Cancer Institute. Started Mar 2026; status: recruiting.
02
Drugs
tpst-1495
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT06557733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06557733.